These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23209648)

  • 1. Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study.
    Tsou YA; Chen KC; Lin HC; Chang SS; Chen CY
    PLoS One; 2012; 7(11):e50087. PubMed ID: 23209648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible strategy against head and neck cancer: in silico investigation of three-in-one inhibitors.
    Tsou YA; Chen KC; Chang SS; Wen YR; Chen CY
    J Biomol Struct Dyn; 2013 Dec; 31(12):1358-69. PubMed ID: 23140436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine?
    Chen KC; Chang SS; Tsai FJ; Chen CY
    J Biomol Struct Dyn; 2013; 31(11):1219-35. PubMed ID: 23146021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico investigation of potential SRC kinase ligands from traditional Chinese medicine.
    Tou WI; Chen CY
    PLoS One; 2012; 7(3):e33728. PubMed ID: 22470466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine.
    Chen KC; Jian YR; Sun MF; Chang TT; Lee CC; Chen CY
    J Biomol Struct Dyn; 2013; 31(11):1207-18. PubMed ID: 23075283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potent EGFR inhibitors from TCM Database@Taiwan.
    Yang SC; Chang SS; Chen HY; Chen CY
    PLoS Comput Biol; 2011 Oct; 7(10):e1002189. PubMed ID: 22022246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers.
    Chen KC; Lee WY; Chen HY; Chen CY
    Biomed Res Int; 2014; 2014():429486. PubMed ID: 25089269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan.
    Chang SS; Huang HJ; Chen CY
    Mol Biosyst; 2011 Dec; 7(12):3366-74. PubMed ID: 22012120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first branching point in porphyrin biosynthesis: a systematic docking, molecular dynamics and quantum mechanical/molecular mechanical study of substrate binding and mechanism of uroporphyrinogen-III decarboxylase.
    Bushnell EA; Erdtman E; Llano J; Eriksson LA; Gauld JW
    J Comput Chem; 2011 Apr; 32(5):822-34. PubMed ID: 20941734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer.
    Ito E; Yue S; Moriyama EH; Hui AB; Kim I; Shi W; Alajez NM; Bhogal N; Li G; Datti A; Schimmer AD; Wilson BC; Liu PP; Durocher D; Neel BG; O'Sullivan B; Cummings B; Bristow R; Wrana J; Liu FF
    Sci Transl Med; 2011 Jan; 3(67):67ra7. PubMed ID: 21270338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome.
    Chen KC; Lee WY; Chen HY; Chen CY
    Biomed Res Int; 2014; 2014():139492. PubMed ID: 25045657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of uroporphyrinogen decarboxylase from Bacillus subtilis.
    Fan J; Liu Q; Hao Q; Teng M; Niu L
    J Bacteriol; 2007 May; 189(9):3573-80. PubMed ID: 17122346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico investigation of potential pyruvate kinase M2 regulators from traditional Chinese medicine against cancers.
    Chen KC; Chen KB; Chen HY; Chen CY
    Biomed Res Int; 2014; 2014():189495. PubMed ID: 25089263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Density-functional study of mechanisms for the cofactor-free decarboxylation performed by uroporphyrinogen III decarboxylase.
    Silva PJ; Ramos MJ
    J Phys Chem B; 2005 Sep; 109(38):18195-200. PubMed ID: 16853337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of human uroporphyrinogen decarboxylase.
    Whitby FG; Phillips JD; Kushner JP; Hill CP
    EMBO J; 1998 May; 17(9):2463-71. PubMed ID: 9564029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.
    Chen KC; Chang SS; Huang HJ; Lin TL; Wu YJ; Chen CY
    J Biomol Struct Dyn; 2012; 30(6):662-83. PubMed ID: 22731403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational design of apolipoprotein E4 inhibitors for Alzheimer's disease therapy from traditional Chinese medicine.
    Huang HJ; Chen HY; Lee CC; Chen CY
    Biomed Res Int; 2014; 2014():452625. PubMed ID: 24967370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key features for designing phosphodiesterase-5 inhibitors.
    Chang TT; Huang HJ; Lee KJ; Yu HW; Chen HY; Tsai FJ; Sun MF; Chen CY
    J Biomol Struct Dyn; 2010 Dec; 28(3):309-21. PubMed ID: 20919747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico identification of potent pancreatic triacylglycerol lipase inhibitors from traditional Chinese medicine.
    Chen KY; Chang SS; Chen CY
    PLoS One; 2012; 7(9):e43932. PubMed ID: 22970152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan.
    Tsai TY; Chang KW; Chen CY
    J Comput Aided Mol Des; 2011 Jun; 25(6):525-31. PubMed ID: 21647737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.